Hu; Qi-Ying
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hu; Qi-Ying.The latest application filed is for "compositions and methods for the delivery of therapeutic agents across the round window membrane".
Company Profile
14.45.54
- Hu; Qi-Ying - Needham MA
- Hu; Qi-Ying - Cambridge MA
- Hu; Qi-Ying - Cambrdige MA
Patent Activity
| Patent | Date |
|---|---|
| Methods for making conjugates from disulfide-containing proteins Grant 11,311,400 - Hu , et al. April 26, 2 | 2022-04-26 |
| Compositions And Methods For The Delivery Of Therapeutic Agents Across The Round Window Membrane App 20220054640 - HU; Qi-Ying ; et al. | 2022-02-24 |
| Hypertonic Pharmaceutical Compositions Containing An Anti-platinum Chemoprotectant Agent App 20210308176 - HU; Qi-Ying ; et al. | 2021-10-07 |
| Cycloalkyne derivatized saccharides Grant 11,135,300 - Adamo , et al. October 5, 2 | 2021-10-05 |
| Cycloalkyne Derivatized Saccharides App 20210268116 - Adamo; Roberto ; et al. | 2021-09-02 |
| Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent Grant 11,071,751 - Hu , et al. July 27, 2 | 2021-07-27 |
| Methods Of Otoprotection Against Platinum-based Antineoplastic Agents App 20210038640 - LEE; John ; et al. | 2021-02-11 |
| Hypertonic Pharmaceutical Compositions Containing An Anti-platinum Chemoprotectant Agent App 20200338119 - HU; Qi-Ying ; et al. | 2020-10-29 |
| Methods of otoprotection against platinum-based antineoplastic agents Grant 10,813,947 - Lee , et al. October 27, 2 | 2020-10-27 |
| Methods For Making Conjugates From Disulfide-containing Proteins App 20200253768 - Kind Code | 2020-08-13 |
| Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent Grant 10,709,732 - Hu , et al. | 2020-07-14 |
| Methods for making conjugates from disulfide-containing proteins Grant 10,667,935 - Hu , et al. | 2020-06-02 |
| Methods For Making Conjugates From Disulfide-containing Proteins App 20190381126 - HU; Qi-Ying ; et al. | 2019-12-19 |
| Hypertonic Pharmaceutical Compositions Containing An Anti-platinum Chemoprotectant Agent App 20190336524 - HU; Qi-Ying ; et al. | 2019-11-07 |
| Methods for making conjugates from disulfide-containing proteins Grant 10,406,198 - Hu , et al. Sept | 2019-09-10 |
| Antibody Drug Conjugates App 20190194315 - ABRAMS; Tinya ; et al. | 2019-06-27 |
| Methods For Making Conjugates From Disulfide-containing Proteins App 20190038444 - HU; Qi-Ying ; et al. | 2019-02-07 |
| Methods for oxime conjugation to ketone-modified polypeptides Grant 10,172,948 - Hu , et al. J | 2019-01-08 |
| Methods for making conjugates from disulfide-containing proteins Grant 10,022,256 - Hu , et al. July 17, 2 | 2018-07-17 |
| Synthetic apelin mimetics for the treatment of heart failure Grant 9,982,017 - Zecri , et al. May 29, 2 | 2018-05-29 |
| Methods For Making Conjugates From Disulfide-containing Proteins App 20170095572 - HU; Qi-Ying ; et al. | 2017-04-06 |
| Use of an adrenal hormone-modifying agent Grant 9,434,754 - Hu , et al. September 6, 2 | 2016-09-06 |
| Cycloalkyne Derivatized Saccharides App 20160166704 - Adamo; Roberto ; et al. | 2016-06-16 |
| Organic compounds Grant 9,278,969 - Ksander , et al. March 8, 2 | 2016-03-08 |
| Methods For Making Conjugates From Disulfide-containing Proteins App 20150290009 - Hu; Qi-Ying ; et al. | 2015-10-15 |
| Tyrosine ligation process Grant 9,149,541 - Adamo , et al. October 6, 2 | 2015-10-06 |
| Synthetic Apelin Mimetics For The Treatment Of Heart Failure App 20150252076 - ZECRI; Frederic ; et al. | 2015-09-10 |
| Organic Compounds App 20150210672 - ADAMS; Christopher Michael ; et al. | 2015-07-30 |
| Synthetic apelin mimetics for the treatment of heart failure Grant 9,067,971 - Zecri , et al. June 30, 2 | 2015-06-30 |
| Methods For Oxime Conjugation To Ketone-modified Polypeptides App 20150150998 - Hu; Qi-Ying ; et al. | 2015-06-04 |
| Organic Compounds App 20140357621 - Ksander; Gary Michael ; et al. | 2014-12-04 |
| Organic Compounds App 20140288126 - ADAMS; Christopher Michael ; et al. | 2014-09-25 |
| Organic Compounds App 20140275175 - Adams; Christopher Michael ; et al. | 2014-09-18 |
| Organic compounds Grant 8,835,646 - Ksander , et al. September 16, 2 | 2014-09-16 |
| Aryl pyridine as aldosterone synthase inhibitors Grant 8,809,545 - Chamoin , et al. August 19, 2 | 2014-08-19 |
| Organic compounds Grant 8,791,141 - Adams , et al. July 29, 2 | 2014-07-29 |
| 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1 Grant 8,778,972 - Hu , et al. July 15, 2 | 2014-07-15 |
| Use of an Adrenal Hormone-Modifying Agent App 20140171392 - Hu; Qi-Ying ; et al. | 2014-06-19 |
| Synthetic Apelin Mimetics For The Treatment Of Heart Failure App 20140142022 - ZECRI; Frederic ; et al. | 2014-05-22 |
| Tyrosine Ligation Process App 20140141034 - Adamo; Roberto ; et al. | 2014-05-22 |
| Synthetic apelin mimetics for the treatment of heart failure Grant 8,673,848 - Zecri , et al. March 18, 2 | 2014-03-18 |
| Use of an adrenal hormone-modifying agent Grant 8,609,862 - Hu , et al. December 17, 2 | 2013-12-17 |
| Aryl Pyridine As Aldosterone Synthase Inhibitors App 20130296309 - Chamoin; Sylvie ; et al. | 2013-11-07 |
| Organic Compounds App 20130287789 - Ksander; Gary Michael ; et al. | 2013-10-31 |
| Aryl pyridine as aldosterone synthase inhibitors Grant 8,519,142 - Chamoin , et al. August 27, 2 | 2013-08-27 |
| Aryl-pyridine derivatives as aldosterone synthase inhibitors Grant 8,519,134 - Allan , et al. August 27, 2 | 2013-08-27 |
| Synthetic Apelin Mimetics For The Treatment Of Heart Failure App 20130196899 - ZECRI; Frederic ; et al. | 2013-08-01 |
| Benzoxazolone derivatives as aldosterone synthase inhibitors Grant 8,455,522 - Hu , et al. June 4, 2 | 2013-06-04 |
| Organic compounds Grant 8,436,035 - Adams , et al. May 7, 2 | 2013-05-07 |
| Aryl pyridine as aldosterone synthase inhibitors Grant 8,383,827 - Chamoin , et al. February 26, 2 | 2013-02-26 |
| Aryl Pyridine As Aldosterone Synthase Inhibitors App 20130035354 - Chamoin; Sylvie ; et al. | 2013-02-07 |
| Aryl-pyridine Derivatives As Aldosterone Synthase Inhibitors App 20120316195 - Allan; Martin ; et al. | 2012-12-13 |
| Use Of An Adrenal Hormone-modifying Agent App 20120295888 - Hu; Qi-Ying ; et al. | 2012-11-22 |
| Organic compounds Grant 8,314,097 - Ksander , et al. November 20, 2 | 2012-11-20 |
| Organic Compounds App 20120277215 - Ksander; Gary Michael ; et al. | 2012-11-01 |
| Organic compounds Grant 8,143,278 - Hu , et al. March 27, 2 | 2012-03-27 |
| Benzoxazolone Derivatives As Aldosterone Synthase Inhibitors App 20120071514 - Hu; Qi-Ying ; et al. | 2012-03-22 |
| 5-pyridin-3-yl-1, 3-dihydro-indol-2-on Derivatives And Their Use As Modulators Of Aldosterone Synthase And/or Cyp11b1 App 20120071512 - Hu; Qi-Ying ; et al. | 2012-03-22 |
| Organic compounds Grant 8,030,334 - Adams , et al. October 4, 2 | 2011-10-04 |
| Organic Compounds App 20110082129 - Adams; Christopher ; et al. | 2011-04-07 |
| Aryl Pyridine As Aldosterone Synthase Inhibitors App 20100292225 - Chamoin; Sylvie ; et al. | 2010-11-18 |
| Organic Compounds App 20100261698 - Adams; Christopher ; et al. | 2010-10-14 |
| Aldosterone Synthase and/or 11B-hydroxylase Inhibitors App 20100240641 - Papillon; Julien ; et al. | 2010-09-23 |
| Organic Compounds App 20100093711 - Hu; Qi-Ying ; et al. | 2010-04-15 |
| Organic Compounds App 20100048562 - Adams; Christopher ; et al. | 2010-02-25 |
| Organic Compounds App 20100041722 - Hu; Qi-Ying ; et al. | 2010-02-18 |
| Organic Compounds App 20090264420 - Ksander; Gary Michael ; et al. | 2009-10-22 |
| Organic compounds App 20070049616 - Ksander; Gary Michael ; et al. | 2007-03-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 